Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Forced Transdifferentiation01:28

Forced Transdifferentiation

2.4K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.4K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K
Tumor Progression02:07

Tumor Progression

7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Forgetting work after work and reviving with full energy at work? A research on the double-edged sword mechanism based on the integrative needs model of crafting.

Acta psychologica·2026
Same author

Epigenetic insights into minimal residual disease detection in cancer.

Genes & diseases·2026
Same author

USP43 promotes gemcitabine resistance by regulating cholesterol homeostasis through E2F1 stabilization in bladder cancer.

Journal of experimental & clinical cancer research : CR·2025
Same author

YKT6 Promotes Bladder Cancer Progression by Stabilizing β-catenin Through USP7-Mediated Deubiquitination.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Optimizing RNA quality in cryopreserved tissues without preservatives: impact of preservatives, thawing methods and tissue aliquot sizes.

BMC biotechnology·2025
Same author

Correction to: Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial-mesenchymal transition in prostate cancer cells.

Medical oncology (Northwood, London, England)·2025

Related Experiment Video

Updated: Feb 24, 2026

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
05:23

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

1.6K

Evolution of Cancer Metastases via Lineage Trans-Differentiation.

Yu Xiao1,2, Wan Jin1,2, Fangjin Chen3

  • 1Department of Biological Repositories, Human Genetic Resources Preservation Center of Hubei Province, Laboratory of Precision Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.

Research (Washington, D.C.)
|February 23, 2026
PubMed
Summary

Cancer cells can change their identity through trans-differentiation, a process crucial for metastasis. This epigenetic reprogramming, linked to MAPK signaling, offers new therapeutic targets for preventing cancer spread.

More Related Videos

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

10.0K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K

Related Experiment Videos

Last Updated: Feb 24, 2026

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
05:23

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

1.6K
The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

10.0K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K

Area of Science:

  • Cancer Biology
  • Epigenetics
  • Cellular Differentiation

Background:

  • While genetic mutations are well-studied in cancer, non-genetic mechanisms driving metastasis are less understood.
  • Cancer metastases often share mutational profiles with primary tumors, suggesting alternative drivers of spread.

Purpose of the Study:

  • To investigate the role of lineage trans-differentiation as a mechanism in cancer metastasis.
  • To elucidate the epigenetic and transcriptional changes underlying metastatic evolution.

Main Methods:

  • Development of bioinformatic tools for single-cell resolution reconstruction of cancer phenotypic evolution.
  • Analysis of transcriptional and epigenomic lineage fidelity during metastatic progression.
  • Correlation of trans-differentiation with clinical data (histopathological grade, survival) and signaling pathways.

Main Results:

  • Cancer cells progressively lose lineage fidelity, de-differentiating into a fetal-like state during premetastatic evolution.
  • Re-differentiation from this state leads to trans-differentiated metastatic cells, a key feature in human and mouse models.
  • Trans-differentiation correlates with poor prognosis and is associated with activated mitogen-activated protein kinase (MAPK) signaling.

Conclusions:

  • Lineage trans-differentiation, driven by epigenetic reprogramming, is a fundamental mechanism of cancer metastasis.
  • Activated MAPK signaling promotes trans-differentiation and metastasis.
  • Reversing trans-differentiation via MAPK inhibition presents a potential therapeutic strategy against cancer spread.